WHO GRADE 3 GLIOMA
Clinical trials for WHO GRADE 3 GLIOMA explained in plain language.
Never miss a new study
Get alerted when new WHO GRADE 3 GLIOMA trials appear
Sign up with your email to follow new studies for WHO GRADE 3 GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered immune cells take on recurrent brain tumors in first human trial
Disease control Recruiting nowThis early-phase study tests a new treatment called anti-GARP CAR T-cell therapy for people with recurrent high-grade glioma, a type of aggressive brain cancer. The therapy involves taking a patient's own immune cells, modifying them in a lab to recognize and attack cancer cells,…
Matched conditions: WHO GRADE 3 GLIOMA
Phase: PHASE1 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
New scan may tell tumor from treatment damage in brain cancer patients
Diagnosis Recruiting nowThis study tests whether a special PET scan using GA-68 PSMA-11 can help doctors tell the difference between a returning brain tumor (glioma) and changes caused by previous treatment. About 25 adults with grade 3 or 4 glioma who are already scheduled for surgery will get this sca…
Matched conditions: WHO GRADE 3 GLIOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated May 26, 2026 04:35 UTC